Peroxisome proliferator-activated receptor-δ genotype influences metabolic phenotype and may influence lipid response to statin therapy in humans: A genetics of diabetes audit and research tayside study

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 4, 2010, Pages 1830-1837

  Burch, Lindsay R ^a   Donnelly, Louise A ^a   Doney, Alex S F ^a   Brady, Jeffrey ^b   Tommasi, Anna M ^b   Whitley, Adrian L ^b   Goddard, Catharine ^b   Morris, Andrew D ^a   Hansen, Michael K ^c   Palmer, Colin N A ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b Translational Medicine Research Collaboration   (United Kingdom)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STATIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; ADIPONECTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; UNITED KINGDOM; ADOLESCENT; AGED; BLOOD; COHORT ANALYSIS; GENETICS; HYPERLIPIDEMIA; METABOLISM; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEXUAL DEVELOPMENT;

ADIPONECTIN; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CHOLESTEROL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; LEPTIN; LIPIDS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR DELTA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX CHARACTERISTICS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77951649533     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1201     Document Type: Article

References (37)

1. Seedorf U, Aberle J 2007 Emerging roles of PPARδ in metabolism. Biochim Biophys Acta 1771:1125-1131
2. Oliver Jr WR, Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL, Lewis MC, Winegar DA, Sznaidman ML, Lambert MH, Xu HE, Sternbach DD, Kliewer SA, Hansen BC, Willson TM 2001 A selective PPARδ agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA 98:5306-5311
3. Tanaka T, Yamamoto J, Iwasaki S, Asaba H, Hamura H, Ikeda Y, Watanabe M, Magoori K, Ioka RX, Tachibana K, Watanabe Y, Uchiyama Y, Sumi K, Iguchi H, Ito S, Doi T, Hamakubo T, Naito M, Auwerx J, Yanagisawa M, Kodama T, Sakai J 2003 Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci USA 100:15924-15929
4. Luquet S, Lopez-Soriano J, Holst D, Fredenrich A, Melki J, Rassoulzadegan M, Grimaldi PA 2003 Peroxisome proliferator-activated receptor δ controls muscle development and oxidative capability. FASEB J 17:2299-2301 (Pubitemid 39561472)
5. Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR, Ham J, Kang H, Evans RM 2004 Regulation of muscle fiber type and running endurance by PPARδ. PLoS Biol 2:e294
6. Klimcakova E, Moro C, Mazzucotelli A, Lolmède K, Viguerie N, Galitzky J, Stich V, Langin D 2007 Profiling of adipokines secreted from human subcutaneous adipose tissue in response to PPAR agonists. Biochem Biophys Res Commun358:897-902 (Pubitemid 46813132)
7. Sprecher DL, Massien C, Pearce G, Billin AN, Perlstein I, Willson TM, Hassall DG, Ancellin N, Patterson SD, Lobe DC, Johnson TG 2007 Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor δ agonist. Arterioscler Thromb Vasc Biol 27:359-365
8. Skogsberg J, Kannisto K, Cassel TN, Hamsten A, Eriksson P, Ehrenborg E 2003 Evidence that PPARδ influences cholesterol metabolism in men. Arterioscler Thromb Vasc Biol 23:637-643
9. Burch LR, Zhou K, Donnelly LA, Doney AS, Brady J, Goddard C, Morris AD, Hansen MK, Palmer CN 2009 A single nucleotide polymorphism on exon-4 of the gene encoding PPARδ is associated with reduced height in adults and children. J Clin Endocrinol Metab 94: 2587-2593
10. Aberle J, Hopfer I, Beil FU, Seedorf U 2006 Association of the T+294C polymorphism in PPAR-δ with low HDL cholesterol and coronary heart disease risk in women. Int J Med Sci 3:108-111
11. Gouni-Berthold I, Giannakidou E, Faust M, Berthold HK, Krone W 2005 The peroxisome proliferator-activated receptor δ +294T/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mellitus type 2 and in non-diabetic controls. Atherosclerosis 183:336-341
12. Grarup N, Albrechtsen A, Ek J, Borch-Johnson K, Jorgensen T, Schmitz O, Hansen T, Pedersen O 2007 Variation in the PPAR-δ gene in relation to common metabolic traits in 7,495 middle-aged white people. Diabetologia 50:1201-1208
13. Wells JCK 2007 Sexual dimorphism of body composition. Best Pract Res Clin Endocrinol Metab 21:415-430
14. Mosher MJ, Lange LA, Howard BV, Lee ET, Best LG, Fabsitz RR, Mccluer JW, North KE 2008 Sex-specific interaction between APOE genotype and carbohydrate intake affects plasma HDL-C levels: the Strong Heart Family Study. Genes Nutr 3:87-97
15. Seda O, Tremblay J, Gaudet D, Brunell PL, Gurau A, Merlo E, Pilote L, Orlov SN, Boulva F, Petrovich M, Kotchen TA, Cowley Jr AW, Hamet P 2008 Systematic, genome-wide, sex-specific linkage of cardiovascular traits in French Canadians. Hypertension 51:1156-1162
16. Guerra B, Fuentes T, Delgado-Guerra S, Guadalupe-Grau A, Olmedillas H, Santana A, Ponce-Gonzalez JG, Dorado C, Calbet JA 2008 Gender dimorphism in skeletal muscle leptin receptors, serum leptin and insulin sensitivity. PLoS One 3:e3466
17. Gui Y, Silha JV, Murphy LJ 2004 Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obes Res 12:1481-1491 (Pubitemid 41137454)
18. Pinilla L, Seoane LM, Gonzalez L, Carro E, Aguilar E, Casanueva FF, Dieguez C 1999 Regulation of serum leptin levels by gonadal function in rats. Eur J Endocrinol 140:468-473
19. Silha JV, Krsek M, Skrha J, Sucharda P, Nyomba BL, Murphy LJ 2003 Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 149: 331-335
20. Yannakoulia M, Yiannakouris N, Blüher S, Matalas AL, Klimis-Zacas D, Mantzoros CS 2003 Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 88:1730-1736
21. Combs TP, Berg AH, Rajala MW, Klebanov S, Iyengar P, Jimenez-Chillaron JC, Patti ME, Klein SL, Weinstein RS, Scherer PE 2003 Sexual differentiation, pregnancy, caloric restriction and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52:268-276
22. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y 2002 Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51:2734-2741
23. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altschuler D 2005 Efficiency and power in genetic association studies. Nat Genet 37:1217-1223
24. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, Sham PC 2007 PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 81:559-575
25. Donnelly LA, Palmer CN, Whitley AL, Lang CC, Doney AS, Morris AD, Donnan PT 2008 Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetics: a Go-DARTS study. Pharmacogenet Genomics 18:279-287
26. Donnelly LA, Doney AS, Morris AD, Palmer CN, Donnan PT 2008 Long-term adherence to statin treatment in diabetes. Diabet Med 25:850-855
27. Kang K, Reilly SM, Karabacak V, Gangl MR, Fitzgerald K, Hatano B, Lee CH 2008 Adipocyte-derived Th2 cytokines and myeloid PPARδ regulate macrophage polarisation and insulin sensitivity. Cell Metab 7:485-495 (Pubitemid 351729204)
28. Odegaard JI, Ricaedo-Gonzalez RR, Red Eagle A, Vats D, Morel CR, Goforth MH, Subramanian V, Mukundan L, Ferrante AW, Chawla A 2008 Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance. Cell Metab 7:496-507
29. Vosper H, Patel L, Graham TL, Khoudoli GA, Hill A, Macphee CH, Pinto I, Smith SA, Suckling KE, Wolf CR, Palmer CNA 2001 The peroxisome proliferator-activated receptor δ promotes lipid accumulation in human macrophages. J Biol Chem 276:44258-44265
30. Lee CH, Olson P, Hevener A, Mehl I, Cong LW, Olefsky JM, Gonzalez FJ, Ham J, Kang H, Peters JM, Evans RM 2006 PPAR-δ regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci USA 103:3444-3449
31. Romanowska M, al Yacoub N, Seidel H, Donandt S, Gerken H, Phillip S, Haritonova N, Artuc M, Schweiger S, Sterry W, Foerster J 2008 PPARδ enhances keratinocyte proliferation in psoriasis and induces heparin-binding EGF-like growth factor. J Invest Derm 128: 110-124
32. Chen S, Tsybouleva N, Ballantyne CM, Gotto Jr AM, Marian AJ 2004 Effects of PPARα, γ, and δ haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis study. Pharmacogenetics 14:61-71
33. Donnelly LA, Doney AS, Dannfald J, Whitley AL, Lang CC, Morris AD, Donnan PT, Palmer CN 2008 A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study. Pharmacogenet Genomics 18:1021-1026
34. Lu JY, Huang KC, Chang LC, Huang YS, Chi YC, Su TC, Chen CL, Yang WS 2008 Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond. J Biomed Sci 15:565-576
35. Vital P, Larrieta E, Hiriart M 2006 Sexual dimorphism in insulin sensitivity and susceptibility to develop diabetes in rats. J Endocrinol 190:425-432 (Pubitemid 44307818)
36. McCarthy JJ 2007 Gene by sex interaction in the etiology of coronary heart disease and the preceding metabolic syndrome. Nutr Metab Cardiovasc Dis 17:153-161
37. Di Carlo C, Tommaselli GA, Nappi C 2002 Effects of sex steroid hormones and menopause on serum leptin concentrations. Gynecol Endocrinol 16:479-491 (Pubitemid 36140303)